Slomiany B L, Piotrowski J, Slomiany A
Research Center, University of Medicine and Dentistry of New Jersey, Newark, USA.
Scand J Gastroenterol. 1998 Sep;33(9):916-22. doi: 10.1080/003655298750026912.
Helicobacter pylori lipopolysaccharide is emerging as a primary factor in the bacterium virulence, and its involvement in causing gastric mucosal responses typical of gastritis has recently been shown. In this study we investigated the effect of the antiulcer agent sucralfate on the expression of regulatory cytokines, tumor necrosis factor-alpha (TNF-alpha) and interleukin-4 (IL-4), and epithelial cell apoptosis during H. pylori lipopolysaccharide-induced acute gastritis.
The experiments were conducted with rats pretreated intragastrically twice daily for 3 days with sucralfate at 100 mg/kg or the vehicle. The rats were then subjected to intragastric surface epithelial application of H. pylori lipopolysaccharide at 50 microg per animal and maintained on the sucralfate or vehicle regimen for an additional 4 days. The animals were killed 16 h after the last dose, and their gastric mucosal tissue used for histologic assessment, quantitation of TNF-alpha and IL-4 expression, and the assay of epithelial cell apoptosis.
In the absence of sucralfate, H. pylori lipopolysaccharide induced acute mucosal responses characterized by the inflammatory infiltration of the lamina propria, hyperemia, and epithelial hemorrhage. This was accompanied by an 11-fold increase in gastric epithelial cell apoptosis and a 9-fold enhancement of the mucosal expression of TNF-alpha, but the level of IL-4 fell by 15%. Intragastric administration of sucralfate produced a 62% reduction in the extent of mucosal damage caused by H. pylori lipopolysaccharide, a 51% decrease in the mucosal expression of TNF-alpha, and a 7-fold reduction in the extent of epithelial cell apoptosis, whereas the expression of IL-4 increased by 52%.
Gastric mucosal inflammatory responses to H. pylori lipopolysaccharide are characterized by a massive enhancement of the proinflammatory cytokine TNF-alpha and epithelial cell apoptosis and repression of IL-4. Our data also show that sucralfate is capable of inducing expression of the regulatory cytokine IL-4 and the suppression of apoptotic events triggered in gastric mucosa by the increase in TNF-alpha that is elicited by H. pylori lipopolysaccharide.
幽门螺杆菌脂多糖正逐渐成为该细菌毒力的主要因素,最近已有研究表明其参与引发典型的胃炎性胃黏膜反应。在本研究中,我们调查了抗溃疡药物硫糖铝对幽门螺杆菌脂多糖诱导的急性胃炎期间调节性细胞因子、肿瘤坏死因子-α(TNF-α)和白细胞介素-4(IL-4)表达以及上皮细胞凋亡的影响。
实验选用大鼠,每天两次经胃内给予100mg/kg硫糖铝或赋形剂,预处理3天。然后,给大鼠胃内表面上皮涂抹每只动物50μg的幽门螺杆菌脂多糖,并继续给予硫糖铝或赋形剂方案,持续4天。在最后一剂给药16小时后处死动物,取其胃黏膜组织进行组织学评估、TNF-α和IL-4表达定量以及上皮细胞凋亡检测。
在未使用硫糖铝的情况下,幽门螺杆菌脂多糖诱导急性黏膜反应,其特征为固有层炎性浸润、充血和上皮出血。这伴随着胃上皮细胞凋亡增加11倍以及黏膜TNF-α表达增强9倍,但IL-4水平下降了15%。胃内给予硫糖铝可使幽门螺杆菌脂多糖引起的黏膜损伤程度降低62%,黏膜TNF-α表达降低51%,上皮细胞凋亡程度降低7倍,而IL-4表达增加52%。
胃黏膜对幽门螺杆菌脂多糖的炎性反应特征为促炎细胞因子TNF-α大量增强、上皮细胞凋亡以及IL-4受抑制。我们的数据还表明,硫糖铝能够诱导调节性细胞因子IL-4的表达,并抑制由幽门螺杆菌脂多糖引发的TNF-α增加所触发的胃黏膜凋亡事件。